Finnegan partner Bryan Diner will co-present "Hatch-Waxman and BPCIA Fundamentals: Understanding Follow-On Products and the Rules for Generic Entry" at American Conference Institute's 35th annual FDA Boot Camp. For more information, or to register, please see ACI's website.
505(b)(2) application, Biologics Price Competition and Innovation Act (BPCIA), data privacy, drugs, duty to disclose, Food and Drug Administration (FDA), Hatch-Waxman Act, new drug application (NDA), Orange Book, patent exclusivity, patent reform, patent term extension
Webinar
February 15, 2024
Webinar
Prosecution First Blog
Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd.
February 9, 2024
Webinar
December 14, 2023
Webinar
Webinar
November 30 2023
Webinar
Webinar
November 28, 2023
Webinar
Federal Circuit IP Blog
August 4, 2023
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.